Filter announcements
Loading...
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
A promoter, [Promoter's Name], has acquired 500,000 equity shares in [Company Name] through open market. This acquisition is worth ₹10 Cr. Their shareholding now stands at 5.25%, up from 5.00% previously, signaling increased confidence.